Document Detail

Factor XI deficiency in the French Basque Country.
MedLine Citation:
PMID:  10444286     Owner:  NLM     Status:  MEDLINE    
Thirty-nine patients with factor XI deficiency were diagnosed in our general hospital, which serves all the French Basque Country (about 290 000 inhabitants), between 1985 and 1995. Biological and clinical data of these cases are reported herein. Factor XI deficiency seems significantly more frequent in Basques than in the other non-Ashkenazi populations. Molecular studies should be performed for typing these cases in the view of population genetics.
F Bauduer; F Dupreuilh; L Ducout; B Marti
Related Documents :
18385006 - Coagulation disorder as a presentation of cystic fibrosis.
16584056 - Hemoglobinization and functional availability of iron for erythropoiesis in case of tha...
25423716 - Primary choriocarcinoma of the fallopian tube: a case report and literature review.
8881666 - Topical vitamin d3 (tacalcitol) for steroid-resistant prurigo.
11653246 - Killing, letting die and the bare difference argument.
17462056 - Efficacy and safety of hormonal treatment of cryptorchidism: current state of the art.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Haemophilia : the official journal of the World Federation of Hemophilia     Volume:  5     ISSN:  1351-8216     ISO Abbreviation:  Haemophilia     Publication Date:  1999 May 
Date Detail:
Created Date:  1999-09-03     Completed Date:  1999-09-03     Revised Date:  2009-10-21    
Medline Journal Info:
Nlm Unique ID:  9442916     Medline TA:  Haemophilia     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  187-90     Citation Subset:  IM    
Department of Clinical Haematology, Centre Hospitalier de la Côte Basque, Bayonne, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Ethnic Groups*
Factor XI Deficiency / ethnology*
France / epidemiology
Middle Aged
Spain / ethnology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective...
Next Document:  Cost-effectiveness analysis of alternative factor VIII products in treatment of haemophilia A.